BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sadeghi A, Tahmasebi S, Mahmood A, Kuznetsova M, Valizadeh H, Taghizadieh A, Nazemiyeh M, Aghebati-Maleki L, Jadidi-Niaragh F, Abbaspour-Aghdam S, Roshangar L, Mikaeili H, Ahmadi M. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls. J Cell Physiol 2021;236:2829-39. [PMID: 32926425 DOI: 10.1002/jcp.30047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Palatella M, Guillaume SM, Linterman MA, Huehn J. The dark side of Tregs during aging. Front Immunol 2022;13:940705. [DOI: 10.3389/fimmu.2022.940705] [Reference Citation Analysis]
2 Almutlaq M, Mansour FA, Alghamdi J, Alhendi Y, Alamro AA, Alghamdi AA, Alamri HS, Alroqi F, Barhoumi T. Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19. IJMS 2022;23:8669. [DOI: 10.3390/ijms23158669] [Reference Citation Analysis]
3 Wu S, Xu Y, Zhang J, Ran X, Jia X, Wang J, Sun L, Yang H, Li Y, Fu B, Huang C, Liao P, Sun W. Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies. Front Immunol 2022;13:893943. [DOI: 10.3389/fimmu.2022.893943] [Reference Citation Analysis]
4 Chen L, Yue J, Zhang S, Bai W, Qin L, Zhang C, Wu B, Li M, Xu S, Jiang Q, Yang L, Xu Q, Zhu R, Xie M, Gong R. SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma. Front Immunol 2022;13:947724. [DOI: 10.3389/fimmu.2022.947724] [Reference Citation Analysis]
5 Belchior-Bezerra M, Lima RS, Medeiros NI, Gomes JAS. COVID-19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances. Obes Rev 2022;:e13496. [PMID: 35837843 DOI: 10.1111/obr.13496] [Reference Citation Analysis]
6 Xu Z, Jiang X, Dai X, Li B. The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection. Front Immunol 2022;13:916411. [DOI: 10.3389/fimmu.2022.916411] [Reference Citation Analysis]
7 Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol 2022. [PMID: 35790881 DOI: 10.1038/s41577-022-00746-9] [Reference Citation Analysis]
8 Vojdani A, Vojdani E, Rosenberg AZ, Shoenfeld Y. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens. Pathophysiology 2022;29:243-80. [DOI: 10.3390/pathophysiology29020020] [Reference Citation Analysis]
9 Ramírez-Martínez G, Jiménez-Álvarez LA, Cruz-Lagunas A, Ignacio-Cortés S, Gómez-García IA, Rodríguez-Reyna TS, Choreño-Parra JA, Zúñiga J. Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae. J Interferon Cytokine Res 2022. [PMID: 35647937 DOI: 10.1089/jir.2021.0222] [Reference Citation Analysis]
10 Liu H, Bai C, Xian F, Liu S, Long C, Hu L, Liu T, Gu X. A high-calorie diet aggravates LPS-induced pneumonia by disturbing the gut microbiota and Th17/Treg balance. J Leukoc Biol 2022. [PMID: 35638590 DOI: 10.1002/JLB.3MA0322-458RR] [Reference Citation Analysis]
11 Russo C, Raiden S, Algieri S, De Carli N, Davenport C, Sarli M, Bruera MJ, Seery V, Sananez I, Simaz N, Bayle C, Nivela V, Ferrero F, Geffner J, Arruvito L. Extracellular ATP and Imbalance of CD4+ T Cell Compartment in Pediatric COVID-19. Front Cell Infect Microbiol 2022;12:893044. [DOI: 10.3389/fcimb.2022.893044] [Reference Citation Analysis]
12 Li W, Ding Z, Chen Y, Wang Y, Peng M, Li C, Zhang H, Zhong R, Xia T, Zhong L, Zhao M, Yang M, Yue Y, Liang L, Cao X, Shu Z. Integrated Pharmacology Reveals the Molecular Mechanism of Gegen Qinlian Decoction Against Lipopolysaccharide-induced Acute Lung Injury. Front Pharmacol 2022;13:854544. [DOI: 10.3389/fphar.2022.854544] [Reference Citation Analysis]
13 ramzannezhad S, Tarighi M, Mohamma dnia-Afrouzi M, Aghapour S, Bagherzadeh M, Ahmadnia Z, Hosseini A, Javanian M, Ghorbani H, Shahbazi M. The association of decreased HLA-G+ immune cell frequencies with critical COVID-19 patients. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105550] [Reference Citation Analysis]
14 Resende GG, da Cruz Lage R, Lobê SQ, Medeiros AF, Costa E Silva AD, Nogueira Sá AT, Oliveira AJA, Sousa D, Guimarães HC, Gomes IC, Souza RP, Aguiar RS, Tunala R, Forestiero F, Bueno Filho JSS, Teixeira MM. Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients - the BISHOP study. Infect Dis (Lond) 2022;:1-9. [PMID: 35485381 DOI: 10.1080/23744235.2022.2066171] [Reference Citation Analysis]
15 Voelkle M, Gregoriano C, Neyer P, Koch D, Kutz A, Bernasconi L, Conen A, Mueller B, Schuetz P. Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study. Nutrients 2022;14:1862. [PMID: 35565831 DOI: 10.3390/nu14091862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Macdougall M, El-hajj Sleiman J, Beauchemin P, Rangachari M. SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Front Immunol 2022;13:871276. [DOI: 10.3389/fimmu.2022.871276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Alsalman A, Al-mterin MA, Elkord E, Dwivedi M. Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19. Journal of Immunology Research 2022;2022:1-13. [DOI: 10.1155/2022/5545319] [Reference Citation Analysis]
18 Zhuang Q, Cai H, Yang M, Peng B, Luo Y, Zhang Y, Ming Y, Dwivedi M. The Association between Regulatory T Cell Subpopulations and Severe Pneumonia Post Renal Transplantation. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/8720438] [Reference Citation Analysis]
19 Cervantes O, Cruz Talavera I, Every E, Coler B, Li M, Li A, Li H, Adams Waldorf K. Role of hormones in the pregnancy and sex‐specific outcomes to infections with respiratory viruses*. Immunological Reviews. [DOI: 10.1111/imr.13078] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wang X, Bai H, Ma J, Qin H, Zeng Q, Hu F, Jiang T, Mao W, Zhao Y, Chen X, Qi X, Li M, Xu J, Hao J, Wang Y, Ding X, Liu Y, Huang T, Fang C, Ge C, Li D, Hu K, Ren X, Zhang B, Zhang B, Shi B, Zhang C. Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients. Front Immunol 2022;13:812514. [PMID: 35281000 DOI: 10.3389/fimmu.2022.812514] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Taus E, Hofmann C, Ibarrondo FJ, Hausner MA, Fulcher JA, Krogstad P, Ferbas KG, Tobin NH, Rimoin AW, Aldrovandi GM, Yang OO. Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination. Front Immunol 2022;13:835830. [PMID: 35273611 DOI: 10.3389/fimmu.2022.835830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Lee J, Kim D, Min B. Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease. Front Immunol 2022;13:865593. [DOI: 10.3389/fimmu.2022.865593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, Aazami H, Seif F. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett 2022;27:10. [PMID: 35109786 DOI: 10.1186/s11658-022-00311-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
24 Darestani MN, Akbari A, Yaghobee S, Taheri M, Akbari S, Guven Y. COVID-19 Pandemic and Periodontal Practice: The Immunological, Clinical, and Economic Points of View. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/3918980] [Reference Citation Analysis]
25 Abdolahi S, Hosseini M, Rezaei R, Mohebbi SR, Rostami-Nejad M, Mojarad EN, Mirjalali H, Yadegar A, Asadzadeh Aghdaei H, Zali MR, Baghaei K. Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects. Infect Genet Evol 2022;98:105207. [PMID: 34999004 DOI: 10.1016/j.meegid.2022.105207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Neagu M, Constantin C, Surcel M. Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic—Experience and Outlines. IJERPH 2021;18:13173. [DOI: 10.3390/ijerph182413173] [Reference Citation Analysis]
27 Asri N, Nazemalhosseini Mojarad E, Mirjalali H, Mohebbi SR, Baghaei K, Rostami-Nejad M, Yadegar A, Rezaei-Tavirani M, Asadzadeh Aghdaei H, Rostami K, Masotti A. Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting immune homeostasis. BMC Gastroenterol 2021;21:462. [PMID: 34895167 DOI: 10.1186/s12876-021-02056-1] [Reference Citation Analysis]
28 Ahmad S, Hatmal MM, Lambuk L, Al-Hatamleh MAI, Alshaer W, Mohamud R. The role of TNFR2+ Tregs in COVID-19: An overview and a potential therapeutic strategy. Life Sci 2021;286:120063. [PMID: 34673116 DOI: 10.1016/j.lfs.2021.120063] [Reference Citation Analysis]
29 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. International Immunopharmacology 2021;101:108217. [DOI: 10.1016/j.intimp.2021.108217] [Reference Citation Analysis]
30 Traxinger BR, Richert-Spuhler LE, Lund JM. Mucosal tissue regulatory T cells are integral in balancing immunity and tolerance at portals of antigen entry. Mucosal Immunol 2021. [PMID: 34845322 DOI: 10.1038/s41385-021-00471-x] [Reference Citation Analysis]
31 Nezgovorova V, Ferretti CJ, Pallanti S, Hollander E. Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. J Psychiatr Res 2021:S0022-3956(21)00674-9. [PMID: 34809994 DOI: 10.1016/j.jpsychires.2021.11.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Vick SC, Frutoso M, Mair F, Konecny AJ, Greene E, Wolf CR, Logue JK, Franko NM, Boonyaratanakornkit J, Gottardo R, Schiffer JT, Chu HY, Prlic M, Lund JM. A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections. Sci Adv 2021;7:eabj0274. [PMID: 34757794 DOI: 10.1126/sciadv.abj0274] [Reference Citation Analysis]
33 Hasan D, Shono A, van Kalken CK, van der Spek PJ, Krenning EP, Kotani T. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling. Purinergic Signal 2021. [PMID: 34757513 DOI: 10.1007/s11302-021-09814-6] [Reference Citation Analysis]
34 Hashemi B, Akram FA, Amirazad H, Dadashpour M, Sheervalilou M, Nasrabadi D, Ahmadi M, Sheervalilou R, Ameri Shah Reza M, Ghazi F, Roshangar L. Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients. J Drug Deliv Sci Technol 2021;:102967. [PMID: 34777586 DOI: 10.1016/j.jddst.2021.102967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 De Simone C, Fargnoli MC, Amerio P, Bianchi L, Esposito M, Pirro F, Potenza C, Ricceri F, Rongioletti F, Stingeni L, Prignano F. Risk of infections in psoriasis: assessment and challenges in daily management. Expert Rev Clin Immunol 2021;17:1211-20. [PMID: 34696673 DOI: 10.1080/1744666X.2021.1997592] [Reference Citation Analysis]
36 Li Z, Wu J, Zhou J, Yuan B, Chen J, Wu W, Mo L, Qu Z, Zhou F, Dong Y, Huang K, Liu Z, Wang T, Symmes D, Gu J, Sho E, Zhang J, Chen R, Xu Y. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases. mBio 2021;12:e0254221. [PMID: 34634931 DOI: 10.1128/mBio.02542-21] [Reference Citation Analysis]
37 Schroeter CB, Huntemann N, Bock S, Nelke C, Kremer D, Pfeffer K, Meuth SG, Ruck T. Crosstalk of Microorganisms and Immune Responses in Autoimmune Neuroinflammation: A Focus on Regulatory T Cells. Front Immunol 2021;12:747143. [PMID: 34691057 DOI: 10.3389/fimmu.2021.747143] [Reference Citation Analysis]
38 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
39 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol 2021;101:108217. [PMID: 34627083 DOI: 10.1016/j.intimp.2021.108217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
40 Aslani M, Mortazavi-Jahromi SS, Mirshafiey A. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs. Int Immunopharmacol 2021;101:108172. [PMID: 34601331 DOI: 10.1016/j.intimp.2021.108172] [Reference Citation Analysis]
41 Takao S, Nakashima T, Masuda T, Namba M, Sakamoto S, Yamaguchi K, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Hamada H, Takahashi S, Nakashima A, Hattori N. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther 2021;12:506. [PMID: 34530920 DOI: 10.1186/s13287-021-02574-5] [Reference Citation Analysis]
42 Jahaj E, Vassiliou AG, Keskinidou C, Gallos P, Vrettou CS, Tsipilis S, Mastora Z, Orfanos SE, Dimopoulou I, Kotanidou A. Evaluating the Role of the Interleukin-23/17 Axis in Critically Ill COVID-19 Patients. J Pers Med 2021;11:891. [PMID: 34575667 DOI: 10.3390/jpm11090891] [Reference Citation Analysis]
43 Xiao LN, Ran X, Zhong YX, Li SS. Clinical value of blood markers to assess the severity of coronavirus disease 2019. BMC Infect Dis 2021;21:921. [PMID: 34488665 DOI: 10.1186/s12879-021-06623-5] [Reference Citation Analysis]
44 Li M, Zhang Y, Lu J, Li L, Gao H, Ma C, Dai E, Wei L. Asymptomatic COVID-19 Individuals Tend to Establish Relatively Balanced Innate and Adaptive Immune Responses. Pathogens 2021;10:1105. [PMID: 34578138 DOI: 10.3390/pathogens10091105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Madonna G, Sale S, Capone M, De Falco C, Santocchio V, Di Matola T, Fiorentino G, Pirozzi C, D'Antonio A, Sabatino R, Atripaldi L, Atripaldi U, Raffone M, Curvietto M, Grimaldi AM, Vanella V, Festino L, Scarpato L, Palla M, Spatarella M, Perna F, Cerino P, Botti G, Parrella R, Montesarchio V, Ascierto PA, Atripaldi L. Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression. Biology (Basel) 2021;10:735. [PMID: 34439967 DOI: 10.3390/biology10080735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Alshammary AF, Al-Sulaiman AM. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences. Virulence 2021;12:1771-94. [PMID: 34251989 DOI: 10.1080/21505594.2021.1929800] [Reference Citation Analysis]
47 Yang B, Yang KD. Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention. Front Immunol 2021;12:690976. [PMID: 34335596 DOI: 10.3389/fimmu.2021.690976] [Reference Citation Analysis]
48 Grant AH, Estrada A 3rd, Ayala-Marin YM, Alvidrez-Camacho AY, Rodriguez G, Robles-Escajeda E, Cadena-Medina DA, Rodriguez AC, Kirken RA. The Many Faces of JAKs and STATs Within the COVID-19 Storm. Front Immunol 2021;12:690477. [PMID: 34326843 DOI: 10.3389/fimmu.2021.690477] [Reference Citation Analysis]
49 Baeten P, Van Zeebroeck L, Kleinewietfeld M, Hellings N, Broux B. Improving the Efficacy of Regulatory T Cell Therapy. Clin Rev Allergy Immunol 2021. [PMID: 34224053 DOI: 10.1007/s12016-021-08866-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Widjaja G, Turki Jalil A, Sulaiman Rahman H, Kamal Abdelbasset W, Bokov DO, Suksatan W, Ghaebi M, Marofi F, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Ahmadi M. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19. Hum Immunol 2021:S0198-8859(21)00174-9. [PMID: 34229864 DOI: 10.1016/j.humimm.2021.06.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Neurath MF. COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34188251 DOI: 10.1038/s41575-021-00480-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
52 Ahmad MF, Ahmad FA, Khan MI, Alsayegh AA, Wahab S, Alam MI, Ahmed F. Ganoderma lucidum: A potential source to surmount viral infections through β-glucans immunomodulatory and triterpenoids antiviral properties. Int J Biol Macromol 2021;187:769-79. [PMID: 34197853 DOI: 10.1016/j.ijbiomac.2021.06.122] [Reference Citation Analysis]
53 Esmaeilzadeh A, Rostami S, Yeganeh PM, Tahmasebi S, Ahmadi M. Recent advances in antibody-based immunotherapy strategies for COVID-19. J Cell Biochem 2021. [PMID: 34160093 DOI: 10.1002/jcb.30017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Del Bello A, Kamar N, Vergez F, Faguer S, Marion O, Beq A, Lathrache Y, Abravanel F, Izopet J, Treiner E. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int 2021:S0085-2538(21)00588-3. [PMID: 34126110 DOI: 10.1016/j.kint.2021.05.032] [Reference Citation Analysis]
55 Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 2021;131:105295. [PMID: 34119855 DOI: 10.1016/j.psyneuen.2021.105295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
56 Mahmoud Salehi Khesht A, Karpisheh V, Qubais Saeed B, Olegovna Zekiy A, Yapanto LM, Nabi Afjadi M, Aksoun M, Nasr Esfahani M, Aghakhani F, Movahed M, Joshi N, Abbaszadeh-Goudarzi K, Hallaj S, Ahmadi M, Dolati S, Mahmoodpoor A, Hashemi V, Jadidi-Niaragh F. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls. Int Immunopharmacol 2021;97:107828. [PMID: 34091116 DOI: 10.1016/j.intimp.2021.107828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Nuzzo D, Vasto S, Scalisi L, Cottone S, Cambula G, Rizzo M, Giacomazza D, Picone P. Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge. J Clin Med 2021;10:1947. [PMID: 34062770 DOI: 10.3390/jcm10091947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wang Y, Zheng J, Islam MS, Yang Y, Hu Y, Chen X. The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci 2021;17:1507-20. [PMID: 33907514 DOI: 10.7150/ijbs.59534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Shahbazi M, Jafari M, Moulana Z, Sepidarkish M, Bagherzadeh M, Rezanejad M, Mirzakhani M, Javanian M, Bayani M, Sadeghi-Haddad-Zavareh M, Mehdinezhad H, Ghadimi R, Ghasemzadeh M, Shokuhi Rad A, Mohammadnia-Afrouzi M. Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019. APMIS 2021;129:271-9. [PMID: 33792109 DOI: 10.1111/apm.13129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, Jadidi-Niaragh F, Adigozalou J, Ahmadi M, Roshangar L. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci 2021;276:119437. [PMID: 33789145 DOI: 10.1016/j.lfs.2021.119437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
61 Vick SC, Frutoso M, Mair F, Konecny AJ, Greene E, Wolf CR, Logue JK, Boonyaratanakornkit J, Gottardo R, Schiffer JT, Chu HY, Prlic M, Lund JM. A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections. medRxiv 2021:2021. [PMID: 33791720 DOI: 10.1101/2021.03.25.21254376] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Wang W, Thomas R, Oh J, Su DM. Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly. Cells 2021;10:628. [PMID: 33808998 DOI: 10.3390/cells10030628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Dauletova M, Hafsan H, Mahhengam N, Zekiy AO, Ahmadi M, Siahmansouri H. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study. Clin Immunol 2021;226:108712. [PMID: 33684527 DOI: 10.1016/j.clim.2021.108712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
64 Sarmiento-Monroy JC, Parra-Medina R, Garavito E, Rojas-Villarraga A. T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications. Viral Immunol 2021;34:190-200. [PMID: 33625297 DOI: 10.1089/vim.2020.0177] [Reference Citation Analysis]